NEW ORLEANS — For people with type 2 diabetes (T2D) inadequately controlled on submaximal dulaglutide (Trulicity) doses, switching to tirzepatide (Mounjaro) produces significantly greater A1c and weight lowering than does escalating dulaglutide treatment. “Often, when we are with a patient who is not meeting treatment goals...
.png)
3773 Howard Ave Las Vegas, NV
877-749-7128 ext. 500
Bruce.Oliver@REIPremiumCapitalLender.com
Copyright © 2023 privatemoneybroker. All Rights Reserved
